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The EGF-CFC factor Oep/Cripto1/Frl1 has been implicated in embryogenesis and several human cancers. During vertebrate
development, Oep/Cripto1/Frl1 has been shown to act as an essential coreceptor in the TGFb/Nodal pathway, which is crucial
for germ layer formation. Although studies in cell cultures suggest that Oep/Cripto1/Frl1 is also implicated in other pathways,
in vivo it is solely regarded as a Nodal coreceptor. We have found that Rasl11b, a small GTPase belonging to a Ras subfamily of
putative tumor suppressor genes, modulates Oep function in zebrafish independently of the Nodal pathway. rasl11b down
regulation partially rescues endodermal and prechordal plate defects of zygotic oep
2/2 mutants (Zoep). Rasl11b inhibitory
action was only observed in oep-deficient backgrounds, suggesting that normal oep expression prevents Rasl11b function.
Surprisingly, rasl11b down regulation does not rescue mesendodermal defects in other Nodal pathway mutants, nor does it
influence the phosphorylation state of the downstream effector Smad2. Thus, Rasl11b modifies the effect of Oep on
mesendoderm development independently of the main known Oep output: the Nodal signaling pathway. This data suggests a
new branch of Oep signaling that has implications for germ layer development, as well as for studies of Oep/Frl1/Cripto1
dysfunction, such as that found in tumors.
Citation: Pe ´zeron G, Lambert G, Dickmeis T, Stra ¨hle U, Rosa FM, et al (2008) Rasl11b Knock Down in Zebrafish Suppresses One-Eyed-Pinhead Mutant
Phenotype. PLoS ONE 3(1): e1434. doi:10.1371/journal.pone.0001434
INTRODUCTION
Endoderm and mesoderm germ layer formation in vertebrate
embryos requires the activity of the conserved TGFb/Nodal
signaling pathway [1,2,3,4,5,6]. Extensive studies in mouse,
Xenopus and zebrafish have allowed the establishment of the
current TGFb/Nodal pathway: Nodal signaling is activated by the
interaction of Nodal ligands with activin (Alk4/ActR-IIB/Taram-
A) receptors [7,8,9,10,11,12] and is regulated extracellularly by an
EGF-CFC coreceptor (see below) and by antagonists belonging to
the TGFb/Lefty family [13,14,15,16]. Nodal signaling is then
transmitted intracellularly by phosphorylation of Smad2, and
Smad2-P translocation in the nucleus in turn induces the
expression of conserved mesendodermal transcription factors (see
[17,18] for review).
Mesendoderm induction by Nodal signaling requires a con-
served EGF-CFC factor encoded by the gene Cripto1 in mouse
[19,20], Frl1 (Fgf receptor ligand 1) in Xenopus [21] and one-eyed-
pinhead (oep) in zebrafish [22,23]. The function of Oep/Cripto1/
Frl1 as a coreceptor of the Nodal pathway has been clearly
demonstrated. In mouse, cripto mutants fail to form embryonic
mesendoderm and resemble the mouse nodal mutant
[10,19,24,25]. Similarly, in zebrafish, embryos lacking both
maternal and zygotic oep function (MZoep, obtained by crossing
rescued oep2/2 adult mutants [22]) display a phenotype similar to
the zebrafish cyclops;squint (cyc;sqt) nodal double mutant [22]. They
have an alterated antero-posterior axis and fail to develop
endoderm, posterior mesoderm and prechordal plate (PP, a
mesendodermal structure). More recently, biochemical analyses
have shown that Oep/Cripto1/Frl1 is required for Nodal ligand
binding to the Alk4/ActR-IIB/Taram-A receptor complex and
subsequent Smad2 phosphorylation [10,26,27].
Other signaling pathways may also require the participation of
EGF-CFC molecule either as a cofactor or as a ligand. For instance,
in Xenopus and zebrafish, Frl1/Oep could function as antagonist of
BMP [28] and more recently, in Xenopus, Frl1 has been implicated
in the Wnt pathway and also been shown to be a coreceptor for
Wnt11 [29]. Moreover, in cell culture, a soluble form of Cripto1 has
been shown to bind the receptor Glypican1 and activate both the
ras/raf/ERK/MAPK and PI3-K/AKT/GSK-3b intracellular sig-
naling pathways, whichare both wellknown for their involvement in
oncogenic processes [30,31,32,33]. Interestingly, Cripto1 has been
found in the conditioned medium of several human carcinoma cell
lines suggesting that a naturally soluble isoform of Cripto1 could act
as a diffusible ligand [34,35,36]. Thus, several reports suggest a
multifunctional capability, both as ligand and as coreceptor of Oep/
Cripto1/Frl1. The role of Oep/Cripto1/Frl1 in pathways other
than Nodal in vivo is still a matter of debate, certainly due in part to
this complexity. The identification of additional elements which
respond to Oep signaling stands to elucidate important signaling
outputs of this protein.
Here we provide genetic data which supports that oep can
influence mesendoderm formation independently of Nodal
signaling. We report the analysis of Rasl11b and the first
developmental function for a member of the Rerg/Rasl11-12
subfamily [37,38,39,40,41]. We find that rasl11b down regulation
acts as a specific suppressor of the oep phenotype and partially
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embryos. Further, Rasl11b activation inhibits mesendoderm
formation only when oep is down regulated, and not in wild-type
embryos. Interestingly, rasl11b loss of function does not rescue
mesendoderm formation in other mutants within the Nodal
pathway and does not affect the activation level of Nodal signaling
as assayed by phosphorylated Smad2 monitoring. This genetic
interaction between oep and rasl11b strongly suggests that Oep can
have a Nodal-Smad2 independent influence on mesendoderm
formation. This study has implication for endoderm and
mesoderm germ layer development but also potentially for analysis
of Oep/Frl1/Cripto1 dysfunction, such as that found in tumors.
RESULTS
Rasl11b is a cytosolic small GTPase
rasl11b cDNA has been isolated from a subtractive library between
embryos expressing a constitutively activated Nodal signaling
pathway and control embryos [42]. Activation of the Nodal
pathway forces most blastomeres to adopt a mesendodermal fate
[43,44], so this strategy was designed to isolate either Nodal
pathway downstream components or other genes specifically
expressed in mesendodermal territories. This library previously
allowed us to isolate the endodermal gene casanova [42] and to
integrate it in the Nodal transcriptional cascade [45]. The Rasl11b
protein is highly conserved among vertebrates (Fig. 1A), sharing on
average 94% homology with its mammalian orthologues. Rasl11b,
along with Rerg [39], Rasl11a [38] and Rasl12/Ris [41],
constitute a poorly documented group of the Ras small GTPase
family [40] (Fig. 1B). Like other members of this particular branch
of GTPases, Rasl11b lacks any known carboxy-terminal recogni-
tion site (such as a CAAX box, A=aliphatic, X=terminal amino
acid) for post-translational lipid modification [39,40,46], which is
used in most Ras small GTPases to allow anchorage to the plasma
membrane (Materials and Methods, and Fig. 1A). Consistent with
this, embryos expressing myc-Rasl11b revealed no accumulation
at the plasma membrane but rather a distribution in the cell
cytoplasm (Fig. 1C).
Rasl11b has a maternal and a zygotic component
In zebrafish embryos, we found that rasl11b was first maternally
expressed and transcripts were homogenously distributed in the
blastoderm during the segmentation stage, as detected using RT–
PCR and ISH (Figs. 2A–B). Then, throughout gastrulation rasl11b
displayed a more restricted zygotic expression at the dorsal margin
(Figs. 2C–F, white arrowheads) and in a bilateral domain at the
animal pole corresponding to the border of the neural plate
(Figs. 2C–F, black arrowheads). During the entire gastrulation
period, rasl11b mRNA was detected in a dorso-ventral gradient at
the dorsal margin and sagittal section revealed expression in both
the hypoblast and epiblast layers at the margin (Fig. 2D). The
rasl11b expression pattern at the margin coincided with presump-
tive mesendodermal territories including the dorsal organizer
[47,48]. Later, during somitogenesis and organogenesis, rasl11b
mRNA was detected in the tailbud and tailtip, the posterior spinal
chord and several head structures including forebrain, isthmic
organizer, hindbrain, hypophysis and pineal gland (Figs. 2G–K).
Finally, at 3 day post-fertilization (dpf) rasl11b expression was only
observed in the otic vesicle (Fig. 2L). Thus, this dynamic
expression pattern could allow rasl11b to function in very early
development events as well as in late organogenesis processes.
Most importantly, for our studies, the dorso-marginal expression
suggests a putative function in endoderm and/or mesoderm germ
layer formation.
rasl11b is expressed in mesendodermal cells and
controlled by the Nodal pathway
We then tested whether rasl11b putative mesendodermal expression
could be modulated by Nodal pathway members (see pathway
Fig. 3A). As expected, the rasl11b marginal expression domain
(Figs. 3B,C) was completely lost in the Nodal signaling-deficient
MZoep mutant (lacks both maternal and zygotic components of oep,
Fig. 3D), which fails to form mesendoderm [22]. We further
examinedthisdorsal expression domaininthenodal mutantscyc and
MZsqt (lacks both maternal and zygotic components of sqt) that have
intermediate Nodal signaling levels [5,6,49,50]. rasl11b marginal
expression was unaffected in cyc gastrulae (Fig. 3E) but was reduced
in MZsqt gastrulae (Fig. 3F). Besides, no change in rasl11b expression
was observed in the Nodal downstream transcriptional effector
mutants or morphants, bonnie and clyde/mixer (bon)[ 5 1 ] ,faust/gata5
[52], mezzo [53], casanova/sox32 (cas)[ 4 2 ]a n dmonorail/foxa2 [54]
(data not shown). Finally, we tested whether activation of Nodal
signaling could induce rasl11b expression in vivo. As expected, wild-
type embryos injected with mRNA encoding the activated form of
the Nodal receptor Tarama (Tar* [43]) displayed ectopic expression
of rasl11b (Fig. 3G). Altogether these results show that rasl11b is
expressed in mesendodermal dorsal territories and its expression
requires the Nodal signaling pathway.
oep has the opposite influence from nodal on
rasl11b dorsal expression
During epistatic analyses, we noticed that zygotic oep (Zoep)m u t a n t
embryos (oep2/2 embryos only containing maternally-expressed
Oep)displayed adramaticincrease ofrasl11bexpressioninthe dorsal
domain(Fig.3H,whitearrowheads).Thisincreasecorrespondstoan
expansion in the mesodermal layer in the antero-posterior (A-P) axis
(comparesagittalsections,Figs.3C,I).Thisresultwassurprisingsince
Zoep phenotype resembles to cyc and MZsqt phenotype’s and is
supposed to be due to a reduction of Nodal signaling. This suggested
either rasl11b expression in mesoderm could be restricted by Oep in
a manner different from Nodals, or Zoep embryos could have a
particular Nodal signal level, different than in Nodal mutants, that
had the opposite impact on rasl11b expression. To discriminate
between these two possibilities and precisely investigate how Nodal
signaling might affect rasl11b expression, we generated a large panel
of embryos expressing different levels of Nodal signal by injecting
different concentrations of the Nodal extracellular inhibitor Lefty
[13,14,15,16].Interestingly,we observed that theinhibitionofNodal
signaling with increasing doses of Lefty leads to a progressive
reduction of rasl11b marginal expression (Figs. 3J–M, here only four
representative doses are displayed). Even with Lefty doses able to
mimic the oep phenotype at 24 hour post-fertilization (hpf), we never
observed any overexpression of rasl11b. This data indicates that the
expansion of rasl11b dorsal expression is a specificity of the Zoep
mutant and is not due to a reduction of Nodal signaling but to the
loss of function of oep and suggests that oep may influence
mesendoderm formation independently of Nodal signaling.
Rasl11b zygotic component has a subtle influence
on antero-posterior axis formation
Rasl11b function was next investigated using morpholino (MO)
knock down and mRNA misexpression experiments. MOs
directed against a gene’s first codon (MO-ATG) blocks translation
of both maternal and zygotic expression, while MOs directed
against a splice donor site (MO-GT) blocks pre-mRNA matura-
tion, thus blocking only zygotic expression (rasl11b maternal
mRNAs are not targeted, Fig. 4A) [55]. Wild-type embryos
Rasl11b Developmental Function
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down phenotype by 24 hpf but no missing structures (Figs. 4B,C).
This phenotype was specific, as it was rescued by injecting rasl11b
mRNA resistant to MO knock down (Materials and Methods,
Fig. 4D), while rasl11b MO potency was confirmed using
translational and RT-PCR assays and the two spliced variants
produced after MO-GT injection were shown to be null as they both
were unable to rescue this curly down phenotype (Figs. 4E–G and
data not shown). Zygotic rasl11b is continuously expressed in the
dorsal margin, the tail bud and tail tip throughout gastrulation and
Figure 1. Rasl11b, an atypical cytoplasmic Ras small GTPase, is strongly conserved in Vertebrates. (A) Zebrafish rasl11b encodes a Ras-related
small GTPase of 244 amino acids (accession number DQ983377) containing the 5 highly conserved domains (G1–G5, overlined in red) responsible for
the guanine nucleotide-dependent molecular switches. Rasl11b has no obvious orthologues in Drosophila melanogaster or Caenorhabditis elegans,
but is highly conserved among vertebrates. Note that, in contrast to most of the Ras small GTPases, Rasl11b lacks a COOH-terminal CAAX motif and
any known recognition signal for C-terminal lipidation found in Ras proteins such as farnesylation or palmitoylation allowing membrane anchorage.
The amino acid positions mutated to create the activated forms Rasl11b
S42V and Rasl11b
Q82L are indicated with stars. (B) Phylogenic analysis of
zebrafish small GTPase proteins. The degree of relatedness is indicated by the length of the vertical lines. Numbers indicate bootstrap support for
nodes. Red box: Rasl11b, Rasl11a, Rasl12 and Rerg constitute an uncharacterized branch of Ras proteins devoid of lipid modification signals. (C)
Epifluorescent microscopy of zebrafish embryonic cells expressing myc-Rasl11b revealed by immunostaining.
doi:10.1371/journal.pone.0001434.g001
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actually be involved in the proper organization of the trunk and tail.
However, the absence of loss of structures in the rasl11b morphant
embryos rather suggests a subtle role in A-P axis formation.
rasl11b knock down partially suppresses oep
phenotype
rasl11b overexpression in the Zoep mutant revealed a particular
genetic interaction between oep and rasl11b. We next analyzed this
interaction by blocking Rasl11b function in Zoep mutant (As for the
epistatic analysis described above, we used the oep
tz57null allele[23]).
Zoep mutants display strong gut and forebrain defects at 24 hpf
[56,57]. However, as mentioned above oep is maternally expressed,
thus depending on the oocyte’s accumulation of maternal oep mRNA
and protein, Zoep larvae have variable head phenotypes. These
phenotypes can be classified in three categories: 1) absence of
forebrain and lens structures, 2) only one lens and 3) two fused lenses
(Fig5B–D).Strikingly,eliminatingmaternalandzygoticcomponents
of rasl11b using MO-ATG partially rescued anterior defects found in
Zoep mutants. Indeed, whereas most of the control embryos did not
develop any lens nor forebrain (85.7%), most of Zoep;rasl11b MO-
ATG larvae displayed a better forebrain development and had one
(51.3%; Fig. 5E) or two lens (23.7%; Fig. 5E). In addition to the head
structure improvement, the gut phenotype in Zoep mutants was also
partially rescued by knock down of rasl11b (Figs. 5F–H). This
suppression of phenotype was also observed in oep morphants
injected with rasl11b MO-ATG, dismissing any allele-specific
interaction between rasl11b and oep (data not shown).
The Zoep phenotype observed at 24 hpf has been shown to be
due to a dramatic reduction of the prechordal plate (PP) and
endoderm formation during gastrulation [56,57]. We thus
analyzed PP formation and endodermal cell number in rasl11b
MO-ATG injected Zoep gastrulae. In all these gastrulae, the PP
was extended (Figs. 5M,N), while the endodermal cell number was
up to 10 times as high as in the controls (Figs. 5R,S). Moreover,
this rescue was inhibited by the co-injection of the MO-resistant
mRNA of rasl11b confirming the specificity of our MO (Fig. 6A
and data not shown). Thus, rasl11b MO-ATG mediated knock
down suppresses a large fraction of Zoep early defects and hence
demonstrates that Rasl11b function is partially responsible for Zoep
phenotype. Interestingly, in contrast to the rescue observed with
the rasl11b MO-ATG, we never observed any rescue in rasl11b
MO-GT injected Zoep embryos. These results point out an
important role of rasl11b maternal expression and suggest that the
increase of rasl11b expression observed in Zoep mutants (Fig. 3H,I)
is unlikely a cause of Zoep endoderm and PP defects. Besides,
rasl11b inhibition did not rescue any defects of MZoep mutant,
showing that the oep maternal expression is required for rasl11b
knock down to be effective. It is most likely that the total absence
of Nodal signaling pathway in MZoep mutant prevents any
formation of dorsal mesendoderm and consequently impedes
Figure 2. rasl11b expression pattern during zebrafish embryogenesis. (A) RT-PCR analysis showing that rasl11b has a maternal and a zygotic
component. RNA extractions have been done before (1 cell stage) and after (gastrula) the midblastula transition, the time of activation of the zygotic
transcription. The maternally and zygotically expressed oep gene and the strictly zygotic sonic hedgehog (shh) gene have been used as controls. (B)
During the cleavage period (dome stage), rasl11b is ubiquitously expressed. (C) At the onset of gastrulation (shield stage), rasl11b is still detected at
the animal pole (Black arrowhead) but is also expressed in a dorso-ventral gradient at the dorsal margin (white arrowhead). This marginal expression
overlaps with the mesendodermal territory in zebrafish embryos. (D) Sagittal section. rasl11b transcript accumulates in both hypoblastic and
epiblastic dorsal blastomeres. (E, F) rasl11b expression is maintained at the margin throughout gastrulation (white arrowheads). Gastrulae also
expressed rasl11b mRNA in ectodermal precursors located at the lateral borders of the blastoderm (black arrowheads). (G–K) During somitogenesis
and organogenesis, rasl11b is expressed in the tail tip and the spinal cord (sc), and in several head structures such as the hindbrain (hb), the isthmic
organizer (i), the otic vesicle (ov), the pineal gland (p), the ventral hypothalamus (h) and the posterior boundary of the telencephalon (t). (J) lateral
close up and (K) frontal view. (L) At 3 dpf, rasl11b is no longer expressed except in the otic vesicle (lateral close up).
doi:10.1371/journal.pone.0001434.g002
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show that rasl11b is a negative modifier that can modulate
mesendoderm formation in Zoep mutant.
Rasl11b activation inhibits endodermal and
prechordal plate development in Oep deficient
embryos
The ability of rasl11b knock down to ameliorate Zoep phenotypes
suggested that rasl11b acts as an inhibitor of mesendoderm
formation. To test this hypothesis we created two constitutively
active Rasl11b molecules by introducing activating mutations
based on the tumor-derived RAS mutations G12V and Q61L [58]
(Materials and Methods, and Fig. 1A), thereafter both named
Rasl11b* because of their similar influence. Rasl11b* mRNAs
were injected in MZoep,Z oep, wild-type and in oep
+/2 embryos
(which are phenotypically wild-type). Injection of Rasl11b* had
minor effects on wild-type embryos, only occasionally reducing the
tail tip (data not shown). It had no effects on MZoep embryos (data
not shown), which do not form any endodermal precursors nor PP.
However, Rasl11b* strongly exacerbated head/forebrain forma-
tion defects in over 80% of the injected Zoep (n=65) and oep
+/2
(n=88) embryos (Figs. 5I–L). While analysis of early markers
showed Rasl11b* had no effect in wild-type gastrulae (data not
shown), Rasl11b* inhibited the remaining expression of PP and
endodermal cell markers in Zoep gastrulae (Figs. 5O,T), and
reduced the PP size and endodermal cell number in oep
+/2
gastrulae (Figs. 5P,Q,U,V). Hence, it appears that Rasl11b activity
inhibits endoderm and PP formation, but only when oep expression
is decreased. This data suggests that Rasl11b is an inhibitor of
mesendoderm formation antagonized or counteracted by Oep.
Rasl11b knock down does not rescue other Nodal
pathway mutants
Theoepphenotypeisgenerallybelievedtobeonlyaconsequenceofa
Nodal signaling decrease, so a simple hypothesis was that Rasl11b
acts as an inhibitor of the Nodal pathway. If this were the case, one
might predict that rasl11b knock down would rescue mesendodermal
defects in other Nodal pathway mutants. To investigate this, the
effect of rasl11b knock down was examined in cyc,M Z sqt, bon and cas
mutants, which are characterized by a reduction in Nodal signaling
and display severe or total absence of PP or endoderm [6,42,49,51].
However, in contrast to Zoep mutant, rasl11b MO-ATG injection
had no effecton anyofthese mutants. Weexamined cyclopia, cardia
Figure 3. Opposite effects of Nodal and Oep on rasl11b expression. (A) Scheme of the Nodal cascade. The Oep coreceptor is necessary for the
binding of the Nodal ligand Cyc and Sqt to the TGFb receptors (containing the type I receptor Taram-A, the zebrafish Alk4 orthologue) that in turn
phosphorylate Smad2. Smad2-P is translocated to the nucleus and triggers the transcription of a first set of genes encoding the transcription factors,
Mixer, Gata5 and Mezzo. This set is required for the expression of the Sox factor Casanova that in turn initiates the transcription of the endodermal
markers sox17 and axial/foxa2. (B–M, Dorsal view of gastrulae save C, I, sagittal sections and G, lateral view) (B, C) In wild-type (WT) embryos rasl11b is
expressed at the animal pole (arrows) and at the dorsal margin (black arrowheads). (D) This marginal expression is lost in MZoep mutants (star),
devoid of maternal and zygotic oep, consequently devoid of Nodal signaling, and so, unable to form most of the mesendoderm. (E, F) rasl11b dorso-
marginal expression is normal in the cyclops Nodal mutant and largely reduced in the MZsquint Nodal mutant. (G) Activation of the Nodal signal by
injection of a constitutively activated form of the Nodal type I receptor Taram-A (tar*) leads to a duplication of the rasl11b marginal expression
domain (likely by inducing a second organizer, white arrowheads) (H, I) In Zoep mutants, devoid of zygotic oep, this mesendodermal expression
domain is extended (white arrowheads). (J–M) A large series of embryos expressing different levels of Nodal signal was generated by injecting
between blastula cells increasing doses of the recombinant Lefty protein, a Nodal pathway extracellular inhibitor. Here, only four representative doses
are displayed. A progressive decrease of rasl11b marginal expression but no expansion was observed, even with concentrations of Lefty able to mimic
aZ oep-like phenotype.
doi:10.1371/journal.pone.0001434.g003
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logical studies and in situ hybridization, yet no rescue was observed
(Fig. 6A and data not shown). Similarly, Rasl11b* mRNA injections
did not exacerbate defects in cyc and MZsqt mutants (data not
shown). These results suggest that Rasl11b does not act as an
inhibitor of Nodal pathway and that the rescue of Zoep mutants by
rasl11b knock down is not due to a simple compensation for a
decrease in Nodal signaling but highlight the specificity of rasl11b
knock down suppressor effect on the Zoep phenotype .
Rasl11b does not act on Smad2 phosphorylation
level
It was still possible that Rasl11b modulates Nodal signaling by
acting specifically via Oep. To investigate this, we monitored
phosphorylation of the Nodal intracellular signal transducer
Smad2 in oep mutants with a normal or down regulated expression
of rasl11b. To detect subtle variations of Smad2 phosphorylation
(Smad2-P) level, we wanted to monitor it in each Zoep or rasl11b
MO-ATG; Zoep embryo. However, a zebrafish embryo at blastula
or gastrula stage does not contain enough material for both a
Smad2 phosphorylation assay and DNA extraction to determine
its Zoep (oep
2/2)o roep
2/+ or oep
+/+ genotype.
To bypass this limitation we performed our experiments on
groups of 100% Zoep-like embryos. To generate these 100%
homogenous Zoep-like groups, we produced clutches of 100% MZoep
embryos (by crossing oep
2/2 fish, see [22] for generation of viable
and fertile oep
2/2 adults) in which we artificially reintroduced an oep
maternal component by injecting at one cell stage a small quantity of
wild-type oep mRNA (0.1pg) mimicking perfectly the Zoep phenotype
(see Materials and Methods). We then compared the number of
endodermal cells and Smad2-P level in Zoep-like embryos and Zoep-
like embryos injected with rasl11b MO-ATG. Whereas rasl11b knock
down improved the Zoep-like embryo phenotype (similarly to what
was observed for Zoep embryos), as assayed by sox17 positive cell
number, this had no effect on Smad2 phosphorylation level (Fig. 6B,
compare 2
nd and 3
rd lanes). To account for possible transient or
stage-specific effects on Smad2-P, we repeated the Smad2-P
detection at different pre-gastrulation stages (Fig. 6C and data not
shown) but we never observed any variation of Smad2-P level. It was
still possible that the rescue was due to a subtle effect on Smad2, too
weak to be detected. To address this possibility, we injected MZoep
eggs with a slightly higher dose of wild-type oep mRNA (0.2 pg)
compared to the dose used to generate Zoep-like embryos (0.1 pg).
Whereas the number of sox17 positive cell was smaller in these
embryos than inrasl11b MO-ATG; Zoep-like embryos(mean of 40 vs
47 cells, Fig. 6B), we observed a clear increase of the corresponding
Smad2-P level (Fig. 6B, compare 3
rd and 4
th lanes). Moreover,
consistently with this observation, the inhibition of rasl11b in MZoep
embryos injected with this higher dose of oep mRNA further
improved their endodermal phenotype but without affecting the
Smad2-P level (Fig. 6B, see last lane).
Finally, confirming this data, we never observed during all our
experiments any transcript level increase of the intermediate
Nodal pathway members downstream of Smad2, i.e. mixer, gata5
and mezzo, in Zoep or Zoep-like embryos injected with rasl11b MO-
ATG. Altogether, these results demonstrate that rasl11b does not
act upstream of Smad2 and confirm that Rasl11b does not
influence the activation level of the Nodal pathway but rather acts
on mesendoderm formation in a Nodal-independent way.
Figure 4. rasl11b knock down induces a specific curly down phenotype in zebrafish. (A) Scheme of the rasl11b transcript. The Morpholino targeted
sequences are represented by thin red lines. The red boxes correspond to the G1 to G5 domains described in Fig. 1. (B–D) Lateral view of 1 dpf
embryos. Both rasl11b MO-ATG and rasl11b MO-GT induce a curly tail down phenotype when injected in WT. This phenotype can be rescued by the
coinjection of rasl11b mRNA resistant to MO knock down, rasl11b
MOr (D). (E) In vitro translational assay showing the efficient knock down effect of the
rasl11b MO-ATG on wild-type rasl11b mRNA compared to the MO resistant rasl11b
MOr mRNA. (F,G) rasl11b splice-blocking morpholino (rasl11b MO-
GT) knocks down endogenous rasl11b mRNA. RT-PCR analysis detected two splice variants that were cloned and sequenced. Sequence comparison
revealed that the splice variant (1) resulted from aberrant splicing to an upstream cryptic slice donor site that is present in intron 2, resulting in an
early frame shift. The splice variant (2) only missed exon 2 but is not functional (data not shown).
doi:10.1371/journal.pone.0001434.g004
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In conclusion, we report here the identification of Rasl11b, a new
small GTPase belonging to a poorly studied subgroup of atypical
cytoplasmic Ras-related GTPases. In vivo functional analyses of
Rasl11b revealed the first developmental role for a member of this
Ras subgroup. rasl11b loss-of-function acts as a specific suppressor
of oep phenotype showing that Rasl11b can function as a negative
modulator of endoderm and prechordal plate formation, and
suggesting a Nodal-independent role of Oep on mesendoderm
formation.
Rasl11b belongs to a poorly understood group of
cytosolic Ras small GTPase
The Ras family of small GTPases is subdivided into Rho, Rab, Arf
and Ras subfamilies. In humans, the Ras subfamily is composed of
35 members classified into 12 structural or functional subgroups
Figure 5. Rasl11b inhibits endoderm and PP formation in an Oep deficient background. (A–D) Frontal views of 1 dpf wild-type embryo and Zoep
embryos. Depending on the quantity of oep mRNA accumulated during oogenesis, Zoep embryos display different levels of anterior structure
development: from absence of lens and forebrain (red class, B), via a cyclopia phenotype (green class, C) to two separate retinae (blue class, D, very
rare). In each clutch, these categories can have slightly different proportions depending on the female, but a large majority of Zoep embryos do not
even develop one retina. Whatever females (n.10) were used for the rasl11b knock down experiments, a drastic rescue (.70%) of the forebrain
formation was always observed, and a large category of embryos with two retinae appeared. (E) Cumulated numbers for each class from 5
independent rasl11b MO-ATG knock down experiments. (F–H) forkhead7 (fkd7) expression pattern in 1 dpf embryos. Gut defects (white arrowheads)
are also rescued (black arrowheads) in Zoep embryos injected by rasl11b MO-ATG. (I–L) 1 dpf embryos lateral views. Rasl11b constitutively activated
forms (Rasl11b*) prevent head formation and disturb the antero-posterior axis formation in Zoep and oep
+/2 but not in wild-type embryos (not
shown). zrx2 is expressed in the retina, krox20 in rhombomeres 3 and 5, myod is expressed in the somitic mesoderm. (M–V) dorsal view of late
gastrulae. rasl11b knock down rescues expression of the prechordal plate marker goosecoid (gsc) and the endodermal marker sox17 in Zoep whereas
Rasl11b* reduces their expression in Zoep and oep
+/2 embryos.
doi:10.1371/journal.pone.0001434.g005
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and Rerg, form one of these subgroups. Most Ras subfamily
proteins are membrane-localized, due to sequence-specific lipid
modifications. These lipid modifications are in turn thought to be
responsible for distinct membrane localization characteristics
[59,60] and signaling properties [61] of Ras GTPases. Interest-
ingly, the Rasl11b subgroup is devoid of all standard lipid
membrane localization signals. Consistent with this, we have
shown that zebrafish Rasl11b localization, like Rerg, is cytosolic. It
is possible that this difference in subcellular localization reflects a
new type of function for the Rasl11b class of small GTPases. This
report is the first to describe a role for a member of this cytosolic
Ras GTPase subgroup, Rasl11b, in development. Other studies
have implicated a role for Rasl11b subgroup members in
oncogenesis. For instance, rasl11a mRNA is less abundant in
some prostate cancers [38], ris/rasl12 tumor suppressor function in
breast cancer is controversial [37,62], and rerg expression inhibits
tumor formation in nude mice and is decreased or lost in primary
human breast tumors [39]. Thus, clarifying the biological role of
this subgroup of small GTPase necessitates further studies.
Rasl11b is an antagonist of Oep function
We show here that inhibition of rasl11b efficiently rescues
formation of endoderm, PP and their derivatives in Zoep embryos.
This rescue is rather dramatic and demonstrates a strong genetic
interaction between rasl11b and oep but it is also remarkable
because mutants or loss-of-functions with suppressor abilities have
not often been described in zebrafish [63,64]. One notable feature
of rasl11b is that, on its own, rasl11b loss-of-function appears to
have little effect on zebrafish normal development. We found that
knock down of rasl11b in wild-type embryos caused no major
defects save a curly down phenotype. Similarly, rasl11b knock
Figure 6. rasl11b interacts specifically with oep but does not affect the Nodal/Smad2 transduction pathway. (A) The MZsqt,M Z oep,Z oep, bon and
cas mutants have a clear reduction of endodermal cells and so were used to quantify the putative impact of rasl11b knock down at different steps/
levels of the nodal pathway. The Zoep mutant was the only one rescued by the rasl11b MO-ATG injection. This rescue was abolished by co-injection
of rasl11b MO-resistant mRNA (rasl11b
MOr). Error bars indicate standard deviation. (B, C) It is impossible to generate clutches of 100% Zoep embryos,
and because one embryo cannot give enough material for both immunoblot and genotyping experiments, 100% Zoep-like mutant clutches were
produced by injecting clutches of 100% MZoep eggs with low doses of wild-type oep mRNA. Half of them were then co-injected with rasl11b MO-
ATG. Each batch was split in two, one used for phosphorylated Smad2 (Smad2-P) level analysis, the second for endodermal cell number count
(assayed by sox17 in situ hybridization). Proteins were detected by western blotting using a Smad2-P antibody. Note that increasing doses of wild-
type oep mRNA were correlated with an increase of Smad2-P and sox17 endodermal cell number, whereas co-injection with rasl11b MO-ATG
increased endodermal cell number without generating more Smad2-P (Error bars indicate standard deviation). The same experiment was done at
three pregastrula stages: dome (B), sphere and 40% epiboly (C).
doi:10.1371/journal.pone.0001434.g006
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defects, as cyc, sqt, bon and cas mutant phenotypes were not affected
by rasl11b knock down. In fact, the effects of Rasl11b knock down
and activation appear to be highly specific to animals which have a
reduced level or function of Oep. rasl11b loss-of-function only
suppresses Zoep and Rasl11b* enhances Zoep phenotype and
aggravates oep
+/2 embryo phenotype (normally wild-type). It is
therefore likely that oep (but not Nodal) acts to prevent the
mesendoderm-inhibiting function of rasl11b, whether directly or in
parallel. In this model, rasl11b role would already be inhibited in a
wild-type context, which is consistent with our finding that rasl11b
knock down has weak phenotype in wild-type embryos. In
conclusion, perhaps Rasl11b modifies the output of Oep influence,
but only in a context where oep expression is decreased.
Alternatively, Rasl11b could act in a parallel pathway whose
activity is only revealed when oep expression is compromised.
Rasl11b does not act on the currently known Nodal
pathway
It is well established that Oep/Frl1/Cripto1 is crucial for Nodal
ligand–receptor association and the cascade leading to mesendo-
derm formation in vertebrates. Thus, our hypothesis was that
Rasl11b acts as an inhibitor of the TGFb/Nodal pathway and
hence we explored very carefully the different possibilities. First, if
Rasl11b acted upstream or at the level of the Oep/Cyc/Sqt/
TGFb receptor complex, rasl11b knock down would have led to an
upregulation of Nodal signaling and so to an increase of the
Smad2-P level and mixer, mezzo and gata5 mRNAs expression.
Second, if Rasl11b acted downstream of the Oep/Cyc/Sqt/TGFb
receptor complex, we would have expected to observe a rescue not
only of Zoep but also at least of the cyc and/or sqt phenotypes. As no
variation of Smad2-P and its downstream targets was observed,
and no other Nodal pathway mutant phenotype (cyc, sqt, mixer,
gata5, cas, foxa2) is suppressed by rasl11b loss-of-function, it is likely
that Rasl11b does not act on the Nodal pathway in its currently
known organization and composition.
Rasl11b suggests the existence of a Nodal-
independent Oep influence on mesendoderm
development
So far, oep/cripto1 has been regarded solely as a component of the
Nodal pathway during development. However, Oep/Frl1/
Cripto1 and Nodals may have independent functional roles:
Nodal inhibits Bone Morphogenetic Protein signaling indepen-
dently of Cripto1, whereas Oep can affect cell motility
independently of Nodals [10,65]. Here we describe two sets of
evidence suggesting that Oep can have a Nodal-independent
function in mesendoderm development. First, the large rasl11b
expression domain in Zoep gastrulae, potentially a consequence of
the expansion of dorsal mesodermal region previously described in
this mutant [56,57], is not due to a weakening of the Nodal
pathway since a reduction in the Nodal ligands (Cyc and Sqt) or an
interference with Lefty does not lead to such an expansion.
Second, Rasl11b knock down and activation dramatically affect
oep
2/2 and oep
+/2 phenotypes but have no effect at all on the
Nodal pathway, strongly suggesting for Oep a role of its own in
endoderm and PP development. This data yields the first
molecular cue for a Nodal-independent role for Oep on
mesendoderm development. Such an oep-rasl11b interaction could
be used, for example, to modulate the mesendodermal specifica-
tion at a very precise cellular level depending on the local
concentration of Oep.
In addition to its role in the Nodal pathway, Oep could
influence mesendoderm formation through other signaling
pathways. For example, in Xenopus, its orthologue Frl1 has been
implicated in the Wnt pathway [29]. Moreover, its mammalian
orthologue Cripto1 has also been implicated in oncogenic
signaling pathways. Cripto1 is well known to produce hyperplasias
and adenocarcinomas in the mammary gland [66]. cripto1 is also
dysregulated in a majority of human carcinomas [66]. In cell
culture, Cripto1 binds Glypican 1 and activates the ras/raf/ERK/
MAPK and PI3-K/AKT/GSK-3b intracellular signaling path-
ways [30,31,32], both of which are involved in regulating cell
proliferation and survival. The precise mechanism by which
Cripto1 activity drives oncogenesis remains unclear. However,
Rasl11b, a member of a putative tumor suppressor subgroup and
only potent when Oep function is compromised, may represent an
undescribed link between Cripto1 and the oncogenic process. This
study prompts an investigation of a putative role for Rasl11b in
oncogenic processes.
Finally, how Oep and Rasl11b interact at the molecular level
remain to be established. Oep is an extracellular factor and Rasl11b
is cytosolic, making a direct interaction in mesendoderm formation
unlikely, except during Oep synthesis and trafficking toward the
cytoplasmic membrane. Further studies will be required to identify
the intermediate actors and signaling pathways that relate the role of
Oep and Rasl11b in the embryo. Here we provide strong evidence
that this interaction does not involve Nodal, the main inductive
pathway involved in mesendoderm formation, suggesting that other
pathways, yet to be identified, are at stake.
MATERIALS AND METHODS
Zebrafish strains
The following mutant alleles were used: oep
tz57, sqt
cz35, cyc
m294,
bon
m425, fau
s26, cas
ta56, mol
tv53a.M Z oep fertile adult fish were generated
as previously described [22]. Crossed together, these fish laid
clutches containing 100% of MZoep embryos. Clutches containing
25% of Zoep (oep
2/2) embryos were obtained by crossing oep
tz57
heterozygous.Zoep-like embryosweregenerated bymicroinjectionof
wild-type oep mRNA (0.1pg or 0.2pg) into MZoep eggs.
Isolation of rasl11b, plasmid construction and
directed mutagenesis
rasl11b cDNA in pSport was isolated from the same substracted
library (embryos with over-activated Nodal signaling versus
controls) that previously allowed us to clone the casanova gene
[42,67]. The rasl11b sequence is deposited at GenBank under the
accession number DQ983377. The coding sequence of rasl11b was
subcloned in the pCS2+ vector for mRNA synthesis. The
Morpholino resistant form rasl11b
MOr and the two constitutively
activated forms rasl11b
S32V, rasl11b
Q82L were generated as
described in the exsite mutagenese kit (Stratagen, La Jolla, CA).
Sequence analyses
Rasl11b protein analysis was performed with Prosite database
http://www.expasy.org and Conserved Domain Database http://
www.ncbi.nlm.nih.gov .
Sequence Accession numbers, alignments and
phylogenic tree
Peptide alignments were performed using the ClustalX interface.
The phylogenic tree was constructed using the neighbor-joining
method. The following peptide sequences were used: Dr Rasl11b,
ABI97979; Gg Rasl11b, ENSGALP00000022564; Hs RASL11B,
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AAH83755; Tr Rasl11b, NEWSINFRUP00000130569; Xl
Rasl11b, DAA02255; Dr Rasl11a, ABK96901; Dr Arf1,
AAS92646; Dr Arf2, AAH66632; Dr Cdc42, AAQ97755; Dr
K-ras, ABF46832; Dr N-ras, AAB40625; Dr Rab5a, AAH49057;
Dr Rab5b, AAH66634; Dr Rab5c, NP_958909; Dr Rab22a,
NP_991282; Dr RalA, AAH53216; Dr RalB, AAH78184; Dr
Ran, AAB97093; Dr Rap1a, AAH71360; Dr Rap1b, AAQ97994;
Dr Rap2b, AAH54999; Dr Rasl12, ENSDARP00000022937; Dr
Rerg, XP_701315; Dr Rhoa, NP_997914; Dr Rhog, NP_956334;
Dr Rhoh, AAX20135. Dr, Danio rerio; Gg, Gallus gallus; Hs, Homo
sapiens; Mm, Mus musculus; Rn, Rattus norvegicus; Tr, Takifugu rubripes;
Xl, Xenopus laevis.
Whole-mount in situ hybridization and
immunostaining
In situ hybridizations and immunohistochemistry were performed
as previously described [68]. For sectioning, embryos were
embedded in resin (JB4, Polysciences). For immunohistochemistry,
polyclonal antibody against Myc-tag (Anti-Myc Tag, Upstate
Biotechnology) was used at 1:500.
RT-PCR
Total RNA was obtained from staged embryos using TRIzol
Reagent (Invitrogen). 1 mg of total RNA was then used to produce
cDNA with the StrataScriptH First Strand cDNA Synthesis Kit
(Stratagene, La Jolla , CA). PCR was performed using the
following primers:
rasl11b-Forward 59-ATGcgtctgatccagaacatg-39;
rasl11b-Reverse 59-gtcacactgaagtgacggtgc-39;
oep-Forward 59-gtgaaagttggggtttctgg-39;
oep-reverse 59-ggacattcgactagcgagaact-39;
shh-forward 59-gactgggtctattacgagtccaaa-39;
shh-reverse 59-gcctgagttcacgcgagaataaat-39.
Morpholino, mRNA and lefty protein microinjection
pCS2+ plasmids containing rasl11b, rasl11b
Q82L, rasl11b
S32V,
rasl11b
MOr, myc-rasl11b, oep, Tar* were linearized with NotI and
sense RNA transcribed with SP6 RNA polymerase using the
mMESSAGE mMACHINE kit (Ambion, Austin, TX). The
sequences of the morpholino oligos (Gene Tools, Philomath,
OR) used in this paper are: rasl11b-MO-ATG 59-TTGA-
CATGTTCTGGATCAGACGCAT-39 and rasl11b-MO-GT 59-
AAACTTACCAACGTTTCTCTCGTAG-39. oep-MO was pre-
viously described [69,70]. 5 silent mismatches were introduced in
the MO-ATG targeted sequence to create rasl11b
MOr:5 9-
ATGCG(T.A)CT(G.A)AT(C.A)CA(G.A)AA(C.T)ATGT-
CAA-39. Lefty injections were performed by injecting Lefty
protein solutions at 12.5; 25; 50; 75; 100 and 200 ng/mli n
PBS+BSA 0.1% (Recombinant-mLefty1, R&D systems, Minnea-
polis, MN) between blastomeres at hight, sphere or dome stages.
Smad2 phosphorylation analysis
Analyses were performed following the standard method with a
chemiluminescent detection kit (Amersham Biosciences). Embryos
devoid of vitellus were resuspended in a Laemmli/RIPA solution
(RIPA: 20 mM Tris pH 8 buffer containing 50 mM NaCl,
50 mM EDTA, 100 mM NaF, 1 mM orthovanadate (NaVO4),
25 mM b-glycerophosphate, 1% NP-40 and a protease inhibitor
cocktail (Roche, Nutley, NJ)). Total proteins were separated by
10% polyacrylamide gels and transferred to Hybond ECL
membranes (Amesham Biosciences) by electroblotting. Polyclonal
antibody against Smad2P (anti-phospho-smad2 antibody, Chemi-
con International) was used at 1:500.
Morpholino efficiency and specificity assay
The rasl11b MO-ATG and rasl11b MO-GT efficiencies were
assayed by in vitro translation and RT-PCR analyses respectively.
For in vitro translation, capped rasl11b and rasl11b
MOr RNA
(20 ng/ml) were translated in vitro in the presence of increasing
concentration of MO-ATG (0.04 to 40 mM) using [
35S] methio-
nine in Rabbit reticulocyte lysate (Promega). RT-PCR was
performed as described above on control embryos and MO-GT
injected embryos. PCR products were analyzed by electrophoresis
and purified for sequencing.
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